Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Gaining Velocity

Why Velocity partnered with Remeditex to invest in POC opportunities

Gaining Velocity

Velocity Pharmaceutical Development LLC thinks its investment partnership withRemeditex Ventureswill give it access to capital and regional deal networks without cluttering the boardroom with too many stakeholders.

The two firms teamed up

Read the full 328 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers